Company Filing History:
Years Active: 2003-2007
Title: Innovations by Robert Seid in Vaccine Development
Introduction
Robert Seid is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of vaccine development, particularly focusing on serogroup B glycoconjugates. With a total of two patents to his name, Seid's work is pivotal in advancing medical science.
Latest Patents
Seid's latest patents include innovative formulations related to serogroup B glycoconjugates. The first patent pertains to glycoconjugates formed from a serogroup B capsular oligosaccharide derivative, where sialic acid residue N-acetyl groups are replaced with N-acyl groups. This invention also covers vaccine formulations containing these glycoconjugates, along with methods for making and using these formulations to treat or prevent serogroup B or K1 disease in mammals. The second patent similarly focuses on serogroup B glycoconjugates and their applications in vaccine formulations.
Career Highlights
Robert Seid is associated with Chiron S.r.l., where he continues to innovate in the field of vaccine research. His work has the potential to impact public health significantly, especially in combating diseases caused by Neisseria meningitidis.
Conclusion
Robert Seid's contributions to vaccine development through his innovative patents highlight his role as a key figure in medical research. His work is essential for advancing treatments that can save lives.